| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antitumour activity and schedule dependency of 8-chloroadenosine-3′,5′-monophosphate (8-ClcAMP) against human tumour xenografts
|
Langdon, S.P.
|
|
1998
|
34 |
3 |
p. 384-388
|
article
|
| 2 |
BRCA1-Positive patients are small for gestational age compared with their unaffected relatives
|
Jernström, H
|
|
1998
|
34 |
3 |
p. 368-371
|
article
|
| 3 |
Commentary
|
Pinkerton, C.R.
|
|
1998
|
34 |
3 |
p. 362-363
|
article
|
| 4 |
comments on: Haemostatic abnormalities in lung cancer: prognostic implications, Buccheri et al., Eur J Cancer, 33, pp. 50–55, 1997
|
Watine, J
|
|
1998
|
34 |
3 |
p. 430
|
article
|
| 5 |
Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer
|
van Laar, J.A.M.
|
|
1998
|
34 |
3 |
p. 296-306
|
article
|
| 6 |
Dipeptidyl peptidase III in malignant and non-malignant gynaecological tissue
|
Šimaga, Š
|
|
1998
|
34 |
3 |
p. 399-405
|
article
|
| 7 |
Editorial
|
|
|
1998
|
34 |
3 |
p. 353-358
|
article
|
| 8 |
Editorial
|
|
|
1998
|
34 |
3 |
p. 277-278
|
article
|
| 9 |
Eight-year results of a prospective non-randomised study on therapy of small breast cancer
|
Rauschecker, H.F
|
|
1998
|
34 |
3 |
p. 315-323
|
article
|
| 10 |
Electronic biomedical journals: how they appear and what they offer
|
Alloro, G
|
|
1998
|
34 |
3 |
p. 290-295
|
article
|
| 11 |
Human transplacental passage of the retinoid fenretinide (4HPR)
|
Formelli, F
|
|
1998
|
34 |
3 |
p. 428-429
|
article
|
| 12 |
Identification of a new commonly deleted region within a 2-cM interval of chromosome 11p11 in breast cancers
|
Nakata, T
|
|
1998
|
34 |
3 |
p. 417-421
|
article
|
| 13 |
Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?
|
Fizazi, K
|
|
1998
|
34 |
3 |
p. 347-352
|
article
|
| 14 |
Irinotecan and 5-Fluorouracil in colorectal cancer: time for a pause?
|
Bulusu, V.R
|
|
1998
|
34 |
3 |
p. 286-289
|
article
|
| 15 |
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer
|
Benedetti-Panici, P.
|
|
1998
|
34 |
3 |
p. 341-346
|
article
|
| 16 |
Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients
|
Oinonen, R.
|
|
1998
|
34 |
3 |
p. 329-336
|
article
|
| 17 |
α-Melanotropin immunoreactivity in human melanoma exudate is related to necrosis
|
Loir, B
|
|
1998
|
34 |
3 |
p. 424-426
|
article
|
| 18 |
Non-Hodgkin’s lymphoma
|
Patte, C
|
|
1998
|
34 |
3 |
p. 359-362
|
article
|
| 19 |
No predictive value of the micronucleus assay for patients with severe acute reaction of normal tissue after radiotherapy
|
Rached, E.
|
|
1998
|
34 |
3 |
p. 378-383
|
article
|
| 20 |
Pharmacokinetics of cisplatin with and without amifostine in tumour-bearing nude mice
|
Korst, A.E.C.
|
|
1998
|
34 |
3 |
p. 412-416
|
article
|
| 21 |
Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice
|
Feleszko, W.
|
|
1998
|
34 |
3 |
p. 406-411
|
article
|
| 22 |
Product review
|
|
|
1998
|
34 |
3 |
p. 427
|
article
|
| 23 |
Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801
|
Curran, D
|
|
1998
|
34 |
3 |
p. 307-314
|
article
|
| 24 |
Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours
|
Csáki, C.
|
|
1998
|
34 |
3 |
p. 364-367
|
article
|
| 25 |
Results of a phase II trial with second-line cystemustine at 60mg/m2 in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group
|
Curé, H.
|
|
1998
|
34 |
3 |
p. 422-423
|
article
|
| 26 |
Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity
|
Sánchez-Rovira, P.
|
|
1998
|
34 |
3 |
p. 394-398
|
article
|
| 27 |
Should cancer patients with incurable disease receive parenteral or enteral nutritional support?
|
Delmore, G
|
|
1998
|
34 |
3 |
p. 282-284
|
article
|
| 28 |
Should cancer patients with incurable disease receive parenteral or enteral nutritional support?
|
Barber, M.D
|
|
1998
|
34 |
3 |
p. 279-282
|
article
|
| 29 |
Should cancer patients with incurable disease receive parenteral or enter nutritional support — bridging editorial
|
Loprinzi, C.L
|
|
1998
|
34 |
3 |
p. 284-285
|
article
|
| 30 |
Survival of breast cancer patients in Lithuania and Norway, 1988–1992
|
Kliukien≐, J
|
|
1998
|
34 |
3 |
p. 372-377
|
article
|
| 31 |
3,3′,4,4′-Tetrachlorobiphenyl (TCB) can enhance DMBA-induced mammary carcinogenesis in the rat
|
Nesaretnam, K
|
|
1998
|
34 |
3 |
p. 389-393
|
article
|
| 32 |
The use of complementary therapies by breast cancer patients attending conventional treatment
|
Crocetti, E
|
|
1998
|
34 |
3 |
p. 324-328
|
article
|
| 33 |
Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma
|
Ellis, L.M.
|
|
1998
|
34 |
3 |
p. 337-340
|
article
|
| 34 |
Why are patients with malignant lymphomas excluded from clinical trials? The experience of an oncology institute in Italy
|
Serraino, D
|
|
1998
|
34 |
3 |
p. 427-428
|
article
|
Journal description